Fabiola Vanegas

525 total citations
9 papers, 418 citations indexed

About

Fabiola Vanegas is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Fabiola Vanegas has authored 9 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 4 papers in Psychiatry and Mental health and 3 papers in Molecular Biology. Recurrent topics in Fabiola Vanegas's work include Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Fabiola Vanegas is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Fabiola Vanegas collaborates with scholars based in United States. Fabiola Vanegas's co-authors include Joaquín N. Lugo, Amy L. Brewster, Anne E. Anderson, Melissa Barker‐Haliski, H. Steve White, Karen S. Wilcox, Timothy H. Pruess, Yan Qian, Vinit Patil and C. Nicole Sunnen and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Epilepsia.

In The Last Decade

Fabiola Vanegas

9 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabiola Vanegas United States 9 213 157 156 85 67 9 418
Timothy H. Pruess United States 13 357 1.7× 321 2.0× 261 1.7× 75 0.9× 80 1.2× 14 606
Sonja Bröer Germany 14 335 1.6× 138 0.9× 257 1.6× 34 0.4× 105 1.6× 25 624
San Nan Yang Taiwan 11 215 1.0× 86 0.5× 67 0.4× 60 0.7× 146 2.2× 20 499
Vicki Shanker United States 13 219 1.0× 98 0.6× 77 0.5× 114 1.3× 48 0.7× 41 603
Mikhil Bamne United States 15 87 0.4× 231 1.5× 100 0.6× 119 1.4× 28 0.4× 22 579
Clarissa F. Cavarsan Brazil 12 220 1.0× 163 1.0× 143 0.9× 18 0.2× 82 1.2× 20 486
Braxton A. Norwood Germany 13 390 1.8× 253 1.6× 342 2.2× 64 0.8× 163 2.4× 18 804
Sookyong Koh United States 5 168 0.8× 113 0.7× 83 0.5× 43 0.5× 76 1.1× 7 373
Yasmin Cruz Del Angel United States 10 207 1.0× 161 1.0× 73 0.5× 19 0.2× 30 0.4× 13 357
Maria Roberta Cilio Italy 5 148 0.7× 92 0.6× 263 1.7× 46 0.5× 202 3.0× 6 447

Countries citing papers authored by Fabiola Vanegas

Since Specialization
Citations

This map shows the geographic impact of Fabiola Vanegas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabiola Vanegas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabiola Vanegas more than expected).

Fields of papers citing papers by Fabiola Vanegas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabiola Vanegas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabiola Vanegas. The network helps show where Fabiola Vanegas may publish in the future.

Co-authorship network of co-authors of Fabiola Vanegas

This figure shows the co-authorship network connecting the top 25 collaborators of Fabiola Vanegas. A scholar is included among the top collaborators of Fabiola Vanegas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabiola Vanegas. Fabiola Vanegas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Metcalf, Cameron S., et al.. (2021). Screening of prototype antiseizure and anti‐inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy. Epilepsia Open. 7(1). 46–58. 18 indexed citations
3.
Smith, Misty D., José H. Woodhead, Timothy H. Pruess, et al.. (2017). Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain. Neurochemical Research. 42(7). 1995–2010. 22 indexed citations
4.
Barker‐Haliski, Melissa, P. R. Billingsley, Zhenmei Lü, et al.. (2017). Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy. Neurochemical Research. 42(7). 1904–1918. 51 indexed citations
5.
Barker‐Haliski, Melissa, et al.. (2016). Acute cognitive impact of antiseizure drugs in naive rodents and corneal‐kindled mice. Epilepsia. 57(9). 1386–1397. 36 indexed citations
6.
Barker‐Haliski, Melissa, E. Jill Dahle, Fabiola Vanegas, et al.. (2016). Acute treatment with minocycline, but not valproic acid, improves long‐term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy. Epilepsia. 57(12). 1958–1967. 42 indexed citations
7.
Barker‐Haliski, Melissa, E. Jill Dahle, Timothy H. Pruess, et al.. (2015). Evaluating an Etiologically Relevant Platform for Therapy Development for Temporal Lobe Epilepsy: Effects of Carbamazepine and Valproic Acid on Acute Seizures and Chronic Behavioral Comorbidities in the Theiler’s Murine Encephalomyelitis Virus Mouse Model. Journal of Pharmacology and Experimental Therapeutics. 353(2). 318–329. 37 indexed citations
8.
Brewster, Amy L., Joaquín N. Lugo, Vinit Patil, et al.. (2013). Rapamycin Reverses Status Epilepticus-Induced Memory Deficits and Dendritic Damage. PLoS ONE. 8(3). e57808–e57808. 96 indexed citations
9.
Sunnen, C. Nicole, Amy L. Brewster, Joaquín N. Lugo, et al.. (2011). Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia. 52(11). 2065–2075. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026